Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | X449Y | IM / LA |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y011017 | SC / RA |
Patient was administered an additional dose of tdap and varicella. The first doses of tdap and varicella were initially administered 1/29/25. Due to an error of verification from a medical assistant, the patient received another dose of tdap and varicella on 2/4/25. Patients mother reported patient to have fever as a side effect which occurred 2/4/25. Patients mother reported fever to last only 3 days. Patients mother gave tylenol to help with fever. Patients mother reported patient to have overcome fever.
No known illnesses
No known chronic or long-standing health conditions
No known medications
No known allergies